Endobronchial Ultrasound to Evaluate Downstaging of Lung Cancer After Combined Chemotherapy and Radiation Treatment
Article Sidebar
Main Article Content
Abstract
Chemotherapy and radiotherapy, separately or sequentially, are established protocols in the management of lung malignancy. However, as early as 1999 a study in Osaka, Japan concluded that the concurrent approach yielded a significantly increased response rate and enhanced median survival duration when compared with the sequential approach [as applied to selected patients with unresectable stage III non-small cell lung cancer (NSCLC)].
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
This article is published under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0). You may copy and redistribute the material for noncommercial purposes, provided that appropriate credit is given and a link to the license is included. Modified versions may not be distributed under this license.
License: https://creativecommons.org/licenses/by-nc-nd/4.0/